Dactolisib(CAS: 915019-65-7)

Dactolisib (CAS: 915019-65-7) is a phosphoinositide 3-kinase (PI3K) inhibitor used in the treatment of certain types of cancer and rare genetic disorders. It is a white to off-white crystalline powder with a molecular formula of C29H29N7O3 and a molecular weight of 525.59.

Dactolisib (CAS: 915019-65-7) is primarily used in the treatment of solid tumors, particularly those with a specific genetic mutation, and in the treatment of a rare genetic disorder called Birt-Hogg-Dubé syndrome. It is also used in clinical trials for other conditions.

Dactolisib (CAS: 915019-65-7) is generally considered safe when used as prescribed under medical supervision. However, it can cause side effects such as nausea, diarrhea, and fatigue. Users should follow all safety guidelines and precautions provided by healthcare professionals to minimize risks.

Dactolisib (CAS: 915019-65-7) should be stored at room temperature (15°C to 30°C) and in a tightly closed container to protect it from moisture. It should be kept away from direct sunlight and stored in a dry place to ensure its stability and efficacy. Avoid freezing or overheating the compound as it may affect its quality and safety.